Chemical Name: 3,5-Dichloro-2-hydroxy-N-(4-methoxy[1,1-biphenyl]-3-yl)-benzenesulfonamide. Alternate Names: ACLYi
ATP citrate lyase (ACL) inhibitor
Molekulargewicht:
424.30
Reinheit:
98% by TLC NMR (Conforms)
Formulierung:
White solid
CAS Nummer:
[943962-47-8]
Formel:
C19H15Cl2NO4S
Anwendungsbeschreibung:
Potent and selective ATP citrate lyase (ACL) inhibitor, IC50=0.13 M. Inhibits lipid biosynthesis, IC50=8 M in HepG2 cells.1,2 Reduces weight gain, lowers plasma cholesterol, triglycerides and glucose in high-fat-fed mice.2 A novel tool compound for exploring the potential of ACL inhibition as a target for metabolic disorders such as obesity and dyslipidemia.2 Impairs proliferation or induces death in androgen-depleted castration resistant prostate cancer cells.3 Reduces cell cycle progression in iBN cells.4
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten